Adenoviruses are commonly used as vectors to deliver therapeutic genes to target cells. Their ability to efficiently infect a variety of cell types makes them ideal for this purpose. However, the use of adenoviral vectors raises safety concerns regarding potential toxicity and immune responses. Researchers are working to modify these vectors to minimize adverse effects, such as reducing their ability to cause systemic inflammation or liver toxicity.
